CoChat

Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?

Kovacicova, Gabriela, Krupova, Yvetta, Lovaszova, Marcela, Obertik, Tanya, Krcmery, Vladimir, Roidova, Alena, Trupl, Jan, Liskova, Anna, Hanzen, Juraj, Milosovic, Peter, Lamosova, Maria, Szovenyiova, Zuzana, Purgelova, Anna, Macekova, Lubica, Bille, Jacques · 2000 · Journal of Infection and Chemotherapy

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

The aim of this study was to test the antifungal susceptibility of 262 bloodstream yeast isolates (164 Candida albicans strain, 88 non-albicans Candida spp. and 10 non-Candida yeasts) recovered from 169 surgical, neonatal, critically ill intensive care unit patients (ICU), and cancer patients (mixed patient population) to amphotericin B (AmB), fluconazole (FLU), 5-flucytosine (5-FC), itraconazole (ITRA), ketoconazole (KETO), miconazole (MICO), and nystatin (NYS), in order to correlate in-vitro resistance to fluconazole with the outcome of fungemia. The agar disk diffusion test was used to assess the susceptibility of the 262 bloodstream yeasts isolates. In addition, 78 strains isolated from cancer patients were also tested with the E-test. There were no differences in the susceptibility of the various C. albicans strains tested, except in 40 isolates from surgery patients, which showed a somewhat lower susceptibility to KETO and MICO to (3.7-5.5% resistance). There were no C. albicans strains resistant to AmB, NYS, or FLU. There were slight differences in the susceptibility patterns of the 88 non-albicans Candida spp. (NAC) isolates. Resistance to AmB and NYS appeared in 1 strain of C. guillermondii (minimum inhibitory concentration; MIC to AmB; 4 microg/ml) and in 1 strain of C. parapsilosis (MIC to NYS, 8 microg/ml and MIC to AmB, 2 microg/ml). All other NACs were susceptible to both polyenes (AmB and NYS). Nine of the 11 strains of C. krusei were resistant to FLU (MIC >or= 64 microg/ml), the 2 exceptions showed, respectively, MICs for FLU of 6 and 32 microg/ml ("dose-dependent" susceptibility). However, only 2 of 29 C. glabrata strains were fully FLU-resistant (MIC >or= 64 microg/ml), 27 being susceptible with MIC values of 0.5-8 microg/ml. Apart from 9 C. krusei and 2 C. glabrata strains, 2 C. parapsilosis strains and 1 strain of C. tropicalis were also FLU-resistant. Among the 88 NACs, 17.04% were FLU-resistant and 3.7% were KETO- and ITRA-resistant. Resistance to 5-FC and AmB was minimal. We compared the outcomes of patients infected with FLU-resistant vs FLU-susceptible yeasts in 161 evaluable patients treated with FLU. Attributable mortality was significantly higher (19.0% vs 8.6%; P < 0.01) in patients infected with the FLU-resistant yeasts.

Overview

Integrity signals

Registry

Crossref · 10.1007/s101560070006

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 6

  1. Clancy, 1998, Correlation of fluconazole MIC and response to therapy for patients with candidemia due to C. albicans and non-C. albicans spp.: results of a multicenter prospective study of candidemia, Abstracts of the IDSA 36th annual meeting, Denver, abstract No., 98
  2. Pappas, 1998, Candidaemia in the United States, Clin Infect Dis 27, 4, 320
  3. Nguyen, 1995, Therapeutic approach in patients with candidaemia, Arch Intern Med 1995;, 155, 2429
  4. Viscoli, 1999, Candidemia in cancer patients. Results of a prospective, multicenter surveillance study in Europe, Clin Infect Dis, 27
  5. Durussel, 1998, Biomic reading of fluconazole agar disk diffusion susceptibility testing of Candida spp. clinical isolates compared to NCCLS microbroth dilution, Abstracts of the 40th ICAAC, 21-24 September, 1998, San Diego, abstract no., 3120
  6. Pfaller, 1999, Etiology and resistance to antifugals in Candida isolates from bloodstream infections, Diagn Microbiol Infect Dis, 27, 331

Cited by

See all 40

Metadata

Authors
Kovacicova, G., Krupova, Y., Lovaszova, M., Obertik, T., Krcmery, V., Roidova, A., Trupl, J., Liskova, A., Hanzen, J., Milosovic, P., Lamosova, M., Szovenyiova, Z., Purgelova, A., Macekova, L., & Bille, J.
Affiliations
University of Trnava (SK)
Corresponding author
Krcmery, Vladimir
Venue
Journal of Infection and Chemotherapy
Publisher
Elsevier BV
Published
2000
Volume
6
Issue
4
Pages
216-221
ISSN
1341-321X (ISSN-L)
OpenAlex
W2026315364
Cited by
39
References
11
Citations by year
2025: 1 · 2024: 1 · 2022: 2 · 2020: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2014: 1 · 2013: 2
FWCI
1.05
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Journal of Infection and Chemotherapy (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
antifungal susceptibility, bloodstream candidiasis, fungemia, fluconazole resistance, Candida albicans, non-albicans Candida, Candida glabrata, Candida krusei, Candida parapsilosis, Candida guilliermondii, amphotericin B, 5-fluorocytosine, itraconazole, ketoconazole, miconazole, nystatin, antifungal resistance, cancer patients, critically ill patients, surgical patients, neonatal patients, treatment outcomes
MeSH terms
Adult, Antifungal Agents, Candida, Candida albicans, Child, Humans, Infant, Newborn, Microbial Sensitivity Tests, Neoplasms, Yeasts, Fluconazole, Survival Analysis, Fungemia, Slovakia, Drug Resistance, Fungal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.